[PDF][PDF] Cervical cancer screening in Latvia: A brief history and recent improvements (2009–2011)
I Vīberga, M Poljak - Acta Dermatovenerol Alp …, 2013 - thejournalhub.s3.amazonaws.com
Screening for cervical cancer (CC) has been an important part of prevention strategies in
Latvia since the early 1960s, reducing its incidence from 31.7/100,000 women in 1963 to …
Latvia since the early 1960s, reducing its incidence from 31.7/100,000 women in 1963 to …
The role of human papilloma virus (HPV) testing in cervical cancer screening
II Mbachu, OS Umeononihu - Afrimedic Journal, 2012 - ajol.info
Background: Cervical cancer is the most studied gynaecologic cancer with a clear natural
history. Screening for the premalignant lesions has reduced the mortality from cervical …
history. Screening for the premalignant lesions has reduced the mortality from cervical …
Five-year cervical (pre) cancer risk of women screened by HPV and cytology testing
MH Uijterwaal, NJ Polman, FJ Van Kemenade… - Cancer Prevention …, 2015 - AACR
Primary human papillomavirus (HPV)–based cervical screening will be introduced in the
Netherlands in 2016. We assessed the 5-year cervical (pre) cancer risk of women with …
Netherlands in 2016. We assessed the 5-year cervical (pre) cancer risk of women with …
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
M Rebolj, K Cuschieri, CS Mathews, F Pesola… - bmj, 2022 - bmj.com
Objectives To provide updated evidence about the risk of cervical intraepithelial neoplasia
grade 3 or higher (CIN3+) and cervical cancer after a negative human papillomavirus (HPV) …
grade 3 or higher (CIN3+) and cervical cancer after a negative human papillomavirus (HPV) …
Cervical cancer in Region Skåne, Sweden 2017–2020 after the implementation of primary HPV screening: A quality assurance audit
C Hellsten, A Holmberg, J Astrom… - Acta Obstetricia et …, 2024 - Wiley Online Library
Introduction Primary human papilloma virus (HPV) screening to detect cervical cancer and
dysplastic lesions was implemented in Region Skåne 2017 for women aged 30–70. The aim …
dysplastic lesions was implemented in Region Skåne 2017 for women aged 30–70. The aim …
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of …
MG Dijkstra, M van Zummeren, L Rozendaal… - bmj, 2016 - bmj.com
Objectives To provide an early risk assessment of extending screening intervals beyond five
years for a human papillomavirus (HPV) based cervical screening programme in the …
years for a human papillomavirus (HPV) based cervical screening programme in the …
[HTML][HTML] Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice
M Schiffman - Preventive medicine, 2017 - ncbi.nlm.nih.gov
Background This special section of Preventive Medicine is devoted to cervical cancer
screening. It covers why and how testing for human papillomavirus (HPV) is replacing …
screening. It covers why and how testing for human papillomavirus (HPV) is replacing …
[HTML][HTML] Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot
Background Cervical cancer screening remains an essential preventive tool worldwide. First
line high-risk Human Papillomavirus (HrHPV) genotyping became gold standard for cervical …
line high-risk Human Papillomavirus (HrHPV) genotyping became gold standard for cervical …
Should human papillomavirus DNA testing be offered in combination with cytology or as a sole primary screening test in cervical cancer prevention?
A Tristram - Future Oncology, 2012 - Taylor & Francis
Evaluation of: Rijkaart DC, Berkhof J, van Kemenade FJ et al. HPV DNA testing in
population-based cervical screening (VUSA-Screen study): results and implications. Br. J …
population-based cervical screening (VUSA-Screen study): results and implications. Br. J …
How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?
Human papillomavirus (HPV) testing is being considered as the primary screening test for
cervical cancer in England, rather than the currently used cytology test. We aimed to …
cervical cancer in England, rather than the currently used cytology test. We aimed to …